PA21259, sbir phase I, developing a RIG-I agonist to prevent covid-19

Ended Formula Grant Awarded Last action

Award ID
R43IP001229
Recipient
Awarding agency
Obligated
$599,901

Award facts

Completion date
Originally
Funding agency
Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Seattle, WA, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$67
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $299,984
Original award $299,984
Show all 15

Subawards

Subrecipient Amount Awarded
Seattle Children's Hospital To evaluate protective efficacy of formulated RAR against SARS-CoV-2 in vitro and against SARS-CoV-2 challenge in mice. $100,000

Quick answers

Who received award R43IP001229?

R43IP001229 was awarded to HDT Bio Corp by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2023.

How much is award R43IP001229 worth?

$599,901 has been obligated on R43IP001229.

Which agency awarded R43IP001229?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001229, with funding from Office of the Director (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award